SynthesisBMC infectious diseases2025
Bacterial profile and antimicrobial resistance patterns among pediatrics patients with suspected bloodstream infections in Ethiopia: a systematic review and meta-analysis.
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Review
- Ceftriaxone-ResistantClinical case reports · 2026Article
- Article
- Neonatal Infections Caused by Multidrug-Resistant Bacteria: An Analysis of Prevalence, Risk Factors, and Therapeutic Implications-A Narrative Review.Pathogens (Basel, Switzerland) · 2026Review
- Methicillin and inducible clindamycin resistance in Gram-positive cocci among GeneXpert-positive pulmonary tuberculosis patients and apparently healthy individuals in Northwest Ethiopia.BMC microbiology · 2026Article
- Gram-negative bloodstream infections in pediatric patients: antimicrobial resistance and factors associated with mortality.Frontiers in pediatrics · 2026Article
- Article
- Article
- Bacterial neonatal sepsis, antimicrobial resistance, and risk factors among neonates in Ethiopia: a systematic review and meta-analysis.Therapeutic advances in infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBloodstream infection (sepsis) represents a systemic inflammatory response to systemic infection by bacteria, fungi, and viruses that can lead to severe complications and death. The therapeutic management to reduce mortality and morbidity associated with sepsis is difficult due partly to (re)emergence of antimicrobial resistance. The choice of empirical antibiotics, therefore, partly depends on the pattern of local/national antibiotic resistance. This systematic review and meta-analysis aimed to determine the prevalence of bacteremia among pediatric patients with suspected bloodstream infections in Ethiopia, based on culture-confirmed bacterial isolates.
methodsA comprehensive search of PubMed, Google Scholar, and grey literature was conducted for studies published between January 2010 and April 2024 on bacterial bloodstream infections and antimicrobial resistance. Laboratory-based observational studies reporting bacterial isolates and resistance patterns were included. Data from 23 eligible studies were extracted independently, organized in Excel, and analyzed using Stata version 14. Pooled prevalence estimates were calculated using a random-effects model. Heterogeneity was assessed via the I² statistic, publication bias through funnel plots and Egger's test, and sensitivity analysis evaluated the influence of individual studies.
resultsThe pooled prevalence of bacterial bloodstream infections (BSIs) among pediatric patients in Ethiopia was 30.66% (95% CI: 27.18-34.15), underscoring a serious public health concern. The most frequently isolated pathogens were Klebsiella species (30.6%), coagulase-negative staphylococci (CoNS), and Staphylococcus aureus, with Gram-negative bacteria comprising 56.65% of isolates. The overall pooled prevalence of multidrug resistance (MDR) was alarmingly high at 80.54%, with 100% resistance observed in both Klebsiella and Acinetobacter species. Subgroup analyses revealed MDR rates of 81.9% in general wards, 78.35% in NICUs, 82.07% among children, and 78.86% among neonates. Regionally, MDR prevalence ranged from 76.7% in Tigray to 91.3% in Addis Ababa, Amhara, and Oromia-highlighting a critical challenge for sepsis treatment and antimicrobial stewardship in Ethiopian pediatric care settings.
conclusionThe findings underscore the urgent need for robust antimicrobial stewardship and enhanced surveillance to combat the growing threat of AMR in pediatric BSIs in Ethiopia. Strengthening routine antimicrobial susceptibility testing, improving healthcare infrastructure, and raising public awareness on responsible antibiotic use are critical. Targeted interventions are essential to guide effective treatment, prevent therapeutic failure, and reduce sepsis-related mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.